Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Biochim Biophys Acta ; 1661(1): 40-6, 2004 Feb 10.
Article in English | MEDLINE | ID: mdl-14967473

ABSTRACT

We have previously demonstrated that Na+, K(+)-ATPase activity is present in both differentiated plasma membranes from Electrophorus electricus (L.) electrocyte. Considering that the alpha subunit is responsible for the catalytic properties of the enzyme, the aim of this work was to study the presence and localization of alpha isoforms (alpha1 and alpha2) in the electrocyte. Dose-response curves showed that non-innervated membranes present a Na+, K(+)-ATPase activity 2.6-fold more sensitive to ouabain (I50=1.0+/-0.1 microM) than the activity of innervated membranes (I50=2.6+/-0.2 microM). As depicted in [3H]ouabain binding experiments, when the [3H]ouabain-enzyme complex was incubated in a medium containing unlabeled ouabain, reversal of binding occurred differently: the bound inhibitor dissociated 32% from Na+, K(+)-ATPase in non-innervated membrane fractions within 1 h, while about 50% of the ouabain bound to the enzyme in innervated membrane fractions was released in the same time. These data are consistent with the distribution of alpha1 and alpha2 isoforms, restricted to the innervated and non-innervated membrane faces, respectively, as demonstrated by Western blotting from membrane fractions and immunohistochemical analysis of the main electric organ. The results provide direct evidence for a distinct distribution of Na+, K(+)-ATPase alpha-subunit isoforms in the differentiated membrane faces of the electrocyte, a characteristic not yet described for any polarized cell.


Subject(s)
Electrophorus/metabolism , Sodium-Potassium-Exchanging ATPase/metabolism , Animals , Blotting, Western , Cell Fractionation , Cell Membrane/chemistry , Cell Membrane/enzymology , Cell Polarity , Electric Organ/enzymology , Microscopy, Confocal , Muscle Proteins , Ouabain/metabolism , Ouabain/pharmacology , Protein Binding , Protein Isoforms/analysis , Protein Isoforms/antagonists & inhibitors , Protein Isoforms/metabolism , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors
2.
Int J Biochem Cell Biol ; 34(9): 1071-9, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12009302

ABSTRACT

The effects of tricyclic antidepressants drugs (TCA) amitriptyline, imipramine and nortriptyline, on purified Electrophorus electricus (L.) acetylcholinesterase (AChE; acetylcholine hydrolase, EC 3.1.1.7) were studied using kinetic methods and specific fluorescent probe propidium. The antidepressants inhibited AChE activity by a non-competitive mechanism. Inhibition constants range from 200 to 400 microM. Dimethylated amitriptyline and imipramine were more potent inhibitors than the monomethylated nortriptyline. Fluorescence measurements using bis-quaternary ligand propidium were used to monitor ligand-binding properties of these cationic antidepressants to the AChE peripheral anionic site (PAS). This ligand exhibited an eight-fold fluorescence enhancement upon binding to the peripheral anionic site of AChE from E. electricus (L.) with K(D)=7 x 10(-7)M. It was observed that TCA drugs displaced propidium from the enzyme. On the basis of the displacement experiments antidepressant dissociation constants were determined. Similar values for the inhibition constants suggest that these drugs have similar affinity to the peripheral anionic site. The results also indicate that the catalytic active center of AChE does not participate in the interaction of enzyme with tricyclic antidepressants. These studies suggest that the binding site for tricyclic antidepressants is located at the peripheral anionic site of E. electricus (L.) acetylcholinesterase.


Subject(s)
Acetylcholinesterase/metabolism , Antidepressive Agents, Tricyclic/pharmacology , Cholinesterase Inhibitors/metabolism , Electrophorus/metabolism , Amitriptyline/pharmacology , Animals , Coloring Agents/metabolism , Imipramine/pharmacology , Molecular Structure , Nortriptyline/pharmacology , Propidium/metabolism , Protein Binding , Spectrometry, Fluorescence
SELECTION OF CITATIONS
SEARCH DETAIL